We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CYTO market cap is 969k. The company's latest EPS is CHF -1.1978 and P/E is -2.54.
Quarter End | Mar 2014 | ||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 0 | ||||
Operating Income | -5.86M | ||||
Net Income | -5.86M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 0 | 0 | 64k | 306k | 158k |
Operating Income | -7.26M | -5.5M | -17.1M | -26.13M | -7.73M |
Net Income | -6.63M | -8.2M | -17.39M | -26.53M | -3.87M |
Quarter End | Mar 2014 | ||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 20.86M | ||||
Total Liabilities | 3.99M | ||||
Total Equity | 16.88M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 9.23M | 20.8M | 18.84M | 6.3M | 7.69M |
Total Liabilities | 3.19M | 4.03M | 6.13M | 14.62M | 1.24M |
Total Equity | 6.04M | 16.77M | 12.71M | -8.32M | 6.46M |
Quarter End | Mar 2014 | ||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -5.19M | ||||
Investing | -57k | ||||
Financing | -87k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -8.39M | -4.84M | -13.67M | -8.68M | -11.51M |
Investing | -3M | -2.32M | -3.51M | -2.14M | 1.45M |
Financing | 7.38M | 16.96M | 6.61M | 9.83M | 10.62M |
Market Cap | 969k |
Price to Earnings Ratio | -2.54 |
Price to Sales Ratio | 62.17 |
Price to Cash Ratio | 15.92 |
Price to Book Ratio | 1.52 |
Dividend Yield | - |
Shares Outstanding | 3.23M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 64.96k |
52 Week Change | -90.68% |
52 Week High | 3.49 |
52 Week Low | 0.30 |
Spread (Intraday) | 0 (0%) |
Company Name | Altamira Therapeutics Ltd |
Address |
dornacherstrasse 210 basel 4053 |
Website | https://altamiratherapeutics.com |
Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions